Dobak John 4
4 · DermTech, Inc. · Filed Jul 2, 2021
Insider Transaction Report
Form 4
DermTech, Inc.DMTK
Dobak John
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2021-07-01$40.91/sh−9,200$376,386→ 459,647 total - Sale
Common Stock
2021-07-01$41.53/sh−3,300$137,062→ 456,347 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2021.
- [F2]This transaction was executed in multiple trades at prices ranging from $40.30 to $41.27, inclusive. The reported price reflects the weighted-average sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $41.34 to $41.77, inclusive. The reported price reflects the weighted-average sale price.
- [F4]The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.